Restatement Determination Date [Axis] Equity Components [Axis] Common Stock [Member] Treasury Stock, Common [Member] Additional Paid-in Capital [Member] Retained Earnings [Member] AOCI Attributable to Parent [Member] Noncontrolling Interest [Member] Plan Name [Axis] 2019 Long Term Equity Incentive Plan [Member] Concentration Risk Type [Axis] Customer Concentration Risk [Member] Concentration Risk Benchmark [Axis] Revenue Benchmark [Member] Customer [Axis] One Customer [Member] Supplier Concentration Risk [Member] Cost of Goods and Service Benchmark [Member] Supplier [Axis] Major Suppliers [Member] Long-Lived Asset, Class [Axis] Other Equipment [Member] Software, Internally Developed [Member] Production Equipment [Member] Statistical Measurement [Axis] Minimum [Member] Maximum [Member] Leasehold Improvements [Member] Product and Service [Axis] Grant [Member] Sales of Goods - Cartidges [Member] Sales of Goods - Readers [Member] Other sales - accessories [Member] Geographical [Axis] UNITED KINGDOM Asia Pacific [Member] Americas [Member] Other Country [Member] Equipment [Member] Software [Member] Other Machinery and Equipment [Member] Intangible Asset, Finite-Lived, Class [Axis] Technology-Based Intangible Assets [Member] Customer Relationships One [Member] Trademarks and Trade Names [Member] Customer Relationships [Member] Preferred Stock [Member] Class of Stock [Axis] Series C Convertible Preferred [Member] Series E Convertible Preferred [Member] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] ATM Agreement [Member] 2025 March ATM Supplement [Member] Legal Entity [Axis] Ladenburg Thalmann & Co. Inc [Member] Subsequent Event Type [Axis] Subsequent Event [Member] At The Market Offering [Member] Inducement Agreement [Member] Reverse Stock Split [Member] Series G and Series H-1 Warrants [Member] Series H-1 Warrants [Member] Series J Warrants [Member] Series H2 Warrants [Member] Seriesj Preferred Stock [Member] Series H2 Preferred Stock [Member] December 2025 Securities Purchase Agreement [Member] Series L Pre-Funded Warrants [Member] Series K-1 Warrants [Member] Series K-2 Warrants [Member] Series K-1 and Series K-2 Warrants [Member] Series K Pre-Funded Warrants [Member] Advisory Agreement [Member] Award Type [Axis] Post-December 2025 Reverse Stock Split [Member] Clear Think Agreement [Member] Restricted Stock [Member] Vesting [Axis] 12-month Anniversary [Member] 48-month Anniversary [Member] Title and Position [Axis] Chief Executive Officer [Member] Chief Financial Officer [Member] Performance Based Restricted Stock Awards [Member] Employees [Member] Cambridge England [Member] CenExel HRI [Member] Cen Exel Clinical Research Inc [Member] Location, Statement of Financial Position, Balance [Axis] Income Tax Jurisdiction [Axis] Income Tax Jurisdiction, Domestic Federal [Member] Income Tax Jurisdiction, Foreign [Member] Antidilutive Securities [Axis] Warrants [Member] Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference ICFR Auditor Attestation Flag Document Financial Statement Error Correction [Flag] Auditor Firm ID Auditor Opinion [Text Block] Auditor Name Auditor Location Statement of Financial Position [Abstract] ASSETS Current assets Cash and cash equivalents Accounts receivable, net Inventories, net Research and development tax incentive receivable Assets held for sale Prepaid expenses and other current assets Total current assets Property and equipment, net Operating lease right-of-use assets Intangibles, net Total assets LIABILITIES AND SHAREHOLDERS’ EQUITY Current liabilities Accounts payable and accrued expenses Current portion of operating lease liabilities Current employee benefit liabilities Notes payable Total current liabilities Employee benefit liabilities, less current portion Operating lease liabilities, less current portion Total liabilities Commitments and contingencies (Note 15) Shareholders’ equity Common stock, $0.01 par value, 100,000,000 shares authorized, 2,905,615 and 2,905,603 shares issued and outstanding, as of June 30, 2026, respectively; 732,339 and 732,327 shares issued and outstanding, as of June 30, 2025, respectively Treasury stock, at cost, 12 shares as of  June 30, 2026 and 2025, respectively Additional paid-in capital Accumulated deficit Accumulated other comprehensive loss Total consolidated Intelligent Bio Solutions Inc. equity Non-controlling interest Total shareholders’ equity TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY Common stock, par value Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding Treasury stock shares Reverse stock split Income Statement [Abstract] Revenue Cost of revenue (exclusive of amortization shown separately below) Gross profit Other income Government support income Operating expenses Selling, general and administrative expenses Development and regulatory approval expenses Depreciation and amortization Impairment of long-lived assets Total operating expenses Loss from operations Other income (expense), net Interest expense Realized foreign exchange gain (loss) Interest income Total other income, net Net loss Net loss attributable to non-controlling interest Net loss attributable to Intelligent Bio Solutions Inc. Other comprehensive (loss) income Foreign currency translation (loss) gain Total other comprehensive (loss) income Comprehensive loss Comprehensive loss attributable to non-controlling interest Comprehensive loss attributable to Intelligent Bio Solutions Inc. Net loss per share, basic Net loss per share, diluted Weighted average shares outstanding, basic Weighted average shares outstanding, diluted Statement [Table] Statement [Line Items] Balance Balance, shares Balance, shares Issuance of restricted stock to vendors Issuance of restricted stock to vendors, shares Issuance of common stock, net of issuance costs At-the-Market Offerings Issuance of common stock, net of issuance costs At Market Offerings, shares Common stock issued for warrants exercised, net of issuance costs Common stock issued for warrants exercised, net of issuance costs, shares Issuance of common stock, net of issuance costs Issuance of common stock, net of issuance costs, shares Issuance of restricted shares to employees Issuance of restricted shares to employees, shares Share based compensation expense Foreign currency translation adjustment Net loss Balance Balance, shares Balance, shares Statement of Stockholders' Equity [Abstract] Statement of Cash Flows [Abstract] Cash flows from operating activities Adjustments to reconcile net loss to cash used in operating activities: Depreciation and amortization Impairment of long-lived assets Provision for credit losses Inventory write-downs Stock-based compensation Non-cash adjustment on R&D expenditure claims Non-cash other operating activities Changes in operating assets and liabilities: Accounts receivable Inventories Grant receivable / deferred grant income Research and development tax incentive receivable Other current assets Accounts payable and accrued expenses Long-term employee benefit liabilities Operating lease liabilities Net cash used in operating activities Cash flows from investing activities Proceeds from sale of assets held for sale Purchase of property and equipment Net cash used in investing activities Cash flows from financing activities Proceeds from issuance of common stock, net of issuance costs Proceeds from issuance of common stock for warrants exercised, net of issuance costs Net cash provided by financing activities Effect of foreign exchange rates on cash and cash equivalents Net increase (decrease) in cash and cash equivalents Cash and cash equivalents, beginning of period Cash and cash equivalents, end of the period Non-cash investing and financing activities Equity issuance costs in accounts payable and accrued expenses Operating lease assets obtained in exchange for operating lease liabilities Issuance of common stock upon cashless exercise of Series F warrants Pay vs Performance Disclosure [Table] Executive Category [Axis] Individual [Axis] Adjustment to Compensation [Axis] Measure [Axis] Pay vs Performance Disclosure, Table Company Selected Measure Name Named Executive Officers, Footnote Peer Group Issuers, Footnote Changed Peer Group, Footnote PEO Total Compensation Amount PEO Actually Paid Compensation Amount Adjustment To PEO Compensation, Footnote Non-PEO NEO Average Total Compensation Amount Non-PEO NEO Average Compensation Actually Paid Amount Adjustment to Non-PEO NEO Compensation Footnote Equity Valuation Assumption Difference, Footnote Compensation Actually Paid vs. Total Shareholder Return Compensation Actually Paid vs. Net Income Compensation Actually Paid vs. Company Selected Measure Total Shareholder Return Vs Peer Group Compensation Actually Paid vs. Other Measure Tabular List, Table Total Shareholder Return Amount Peer Group Total Shareholder Return Amount Net Income (Loss) Company Selected Measure Amount Other Performance Measure, Amount Adjustment to Compensation, Amount PEO Name Name Non-GAAP Measure Description Additional 402(v) Disclosure Pension Benefits Adjustments, Footnote Equity Awards Adjustments, Footnote Erroneously Awarded Compensation Recovery [Table] Restatement Determination Date Aggregate Erroneous Compensation Amount Erroneous Compensation Analysis Stock Price or TSR Estimation Method Outstanding Aggregate Erroneous Compensation Amount Aggregate Erroneous Compensation Not Yet Determined Name Forgone Recovery due to Expense of Enforcement, Amount Forgone Recovery due to Violation of Home Country Law, Amount Forgone Recovery due to Disqualification of Tax Benefits, Amount Forgone Recovery, Explanation of Impracticability Name Compensation Amount Restatement does not require Recovery Award Timing Disclosures [Line Items] Award Timing MNPI Disclosure Award Timing Method Award Timing Predetermined Award Timing MNPI Considered Award Timing, How MNPI Considered MNPI Disclosure Timed for Compensation Value Awards Close in Time to MNPI Disclosures, Table Name Underlying Securities Exercise Price Fair Value as of Grant Date Underlying Security Market Price Change Insider Trading Arrangements [Line Items] Material Terms of Trading Arrangement Name Title Rule 10b5-1 Arrangement Adopted Non-Rule 10b5-1 Arrangement Adopted Adoption Date Rule 10b5-1 Arrangement Terminated Non-Rule 10b5-1 Arrangement Terminated Termination Date Expiration Date Arrangement Duration Aggregate Available Insider Trading Policies and Procedures [Line Items] Insider Trading Policies and Procedures Adopted Insider Trading Policies and Procedures Not Adopted Cybersecurity Risk Management, Strategy, and Governance [Abstract] Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block] Cybersecurity Risk Management Processes Integrated [Flag] Cybersecurity Risk Management Processes Integrated [Text Block] Cybersecurity Risk Management Third Party Engaged [Flag] Cybersecurity Risk Third Party Oversight and Identification Processes [Flag] Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag] Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block] Cybersecurity Risk Board of Directors Oversight [Text Block] Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block] Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block] Cybersecurity Risk Role of Management [Text Block] Cybersecurity Risk Management Positions or Committees Responsible [Flag] Cybersecurity Risk Management Positions or Committees Responsible [Text Block] Cybersecurity Risk Management Expertise of Management Responsible [Text Block] Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block] Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag] Material Cybersecurity Incident [Abstract] Material Cybersecurity Incident Nature [Text Block] Material Cybersecurity Incident Scope [Text Block] Material Cybersecurity Incident Timing [Text Block] Material Cybersecurity Incident Material Impact or Reasonably Likely Material Impact [Text Block] Material Cybersecurity Incident Information Not Available or Undetermined [Text Block] Organization, Consolidation and Presentation of Financial Statements [Abstract] ORGANIZATION AND DESCRIPTION OF THE BUSINESS LIQUIDITY AND GOING CONCERN Accounting Policies [Abstract] SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Segment Reporting [Abstract] SEGMENT REPORTING Credit Loss [Abstract] ACCOUNTS RECEIVABLE, NET Inventory Disclosure [Abstract] INVENTORIES, NET Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract] PREPAID EXPENSES AND OTHER CURRENT ASSETS Property, Plant, and Equipment [Abstract] PROPERTY AND EQUIPMENT, NET Intangible Asset, Goodwill and Other [Abstract] INTANGIBLE ASSETS, NET Payables and Accruals [Abstract] ACCOUNTS PAYABLE AND ACCRUED EXPENSES Debt Disclosure [Abstract] NOTE PAYABLE Leases LEASES Equity [Abstract] SHAREHOLDERS’ EQUITY Share-Based Payment Arrangement [Abstract] SHARE-BASED COMPENSATION Commitments and Contingencies Disclosure [Abstract] COMMITMENTS AND CONTINGENCIES Income Tax Disclosure [Abstract] INCOME TAX Earnings Per Share [Abstract] LOSS PER SHARE Subsequent Events [Abstract] SUBSEQUENT EVENTS Basis of presentation Principles of consolidation Use of estimates Segment Reporting Accounts Receivable and Allowances for Credit Losses Stock-Based Compensation Cash and cash equivalents Concentration of credit risk Fair value measurements Inventories, net Equity offering costs Property and Equipment, net Leases Intangible assets Long-lived assets Assets held for sale Revenue recognition Government support income Selling, general and administrative expenses (SG&A) Development and regulatory approval costs Warrants Employee benefits Foreign currency Comprehensive income (loss) Income taxes Net loss per share Reclassification Recent accounting pronouncements SCHEDULE OF DISAGGREGATES REVENUE BY PRODUCT TYPE SCHEDULE OF GOVERNMENT SUPPORT INCOME SCHEDULE OF REVENUE, GOVERNMENT SUPPORT INCOME, NET LOSS AND LONG LIVED ASSETS AND INVENTORIES SCHEDULE OF ACCOUNTS RECEIVABLE SCHEDULE OF INVENTORIES SCHEDULE OF OTHER CURRENT ASSETS SCHEDULE OF PROPERTY AND EQUIPMENT SCHEDULE OF OTHER INTANGIBLE ASSETS SCHEDULE OF EXPECTED AMORTIZATION EXPENSES FOR INTANGIBLE ASSETS SCHEDULE OF ACCOUNTS PAYABLE AND ACCRUED EXPENSES SCHEDULE OF LEASE EXPENSES SCHEDULE OF MATURITIES OF OPERATING LEASES TO OPERATING LEASE LIABILITIES SCHEDULE OF NON VESTED ACTIVITY RELATED TO RESTRICTED STOCK AWARDS SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES SCHEDULE OF EFFECTIVE INCOME TAX RATE RECONCILIATION SCHEDULE OF BASIC LOSS PER COMMON SHARE POTENTIAL DILUTIVE SECURITIES SCHEDULE OF ANTI-DILUTIVE WARRANTS Net losses Shareholders' equity Working capital Accumulated deficit Cash and Cash Equivalent Nature of Operation, Product Information, Concentration of Risk [Table] Product Information [Line Items] Total revenue Grant income Research and development (“R&D”) tax refund Total government support income Allowance for credit losses Share issuance of common stock Share available for issuance of stock Cash equivalents Insured limits Concentration of credit risk Property plant and equipment useful life Property, Plant, and Equipment, Useful Life, Term, Description [Extensible Enumeration] Impairment of log lived assets Proceeds from sale of productive assets Deferred grant income Grant audit Long-Term Debt Tax credit of refund description Research and development tax refund R&D tax incentive receivable Likelihood, settlement Uncertain tax positions Accrued Interest or penalties Segment Reporting, Entity-Wide Information Not Provided as Part of Reportable Segment, Geographical Area, Revenue and Long-Lived Asset [Table] Segment Reporting, Entity-Wide Information Not Provided as Part of Reportable Segment, Geographical Area, Revenue and Long-Lived Asset [Line Items] Total Government Support Income Segment net income (loss) Total Long-Lived Assets Total Inventories Total Long-Lived Assets and Inventories, net Add: Government support income Less: Cost of revenue (exclusive of amortization shown separately below) Selling, general and administrative expenses Other segment items Accounts receivable Less: Allowance for credit losses Accounts receivable, net Raw material Work-in-progress Finished goods Inventories, net Inventory write down Prepayments Goods and services tax receivable Deposits Other receivables Total Property, Plant, and Equipment [Table] Property, Plant, and Equipment [Line Items] Gross property and equipment Less: accumulated depreciation and amortization Property and equipment, net Depreciation of property and equipment Intangible Asset, Finite-Lived [Table] Intangible Asset, Finite-Lived [Line Items] Weighted average useful lives (years) Remaining weighted average useful lives (years) Acquisition cost Effect of foreign currency Accumulated amortization Carrying value Weighted average useful lives (years) 2027 2028 2029 2030 Total Amortization of intangible assets Accounts payable Government grant refund payable Accrual - other expenses Accrual - research and development expenses Goods and services tax payable Accrued compensation and related payables Total Accrues interest Debt instrument, description Note payable Schedule Of Lease Expenses Operating lease costs Total operating lease costs Schedule Of Maturities Of Operating Leases To Operating Lease Liabilities 2027 2028 2029 2030 2031 Thereafter Total lease payments Less: imputed interest Lease liabilities Less: current portion of operating lease liabilities Total operating lease liabilities, less current portion Cash paid for leases Weighted average remaining lease term Weighted average, discount rate Accumulated Other Comprehensive Income (Loss) [Table] Accumulated Other Comprehensive Income (Loss) [Line Items] Preferred stock, shares authorized Preferred stock, par value Preferred stock, shares designated Preferred stock, shares issued Preferred stock, shares outstanding Additional warrant to purchase of shares Warrants exercise price Share price Sale of stock, value Sale of stock, value Commissions paid Sale of stock, shares Warrants and outstanding common stock equal Class of warrant or right number of securities called by warrants or rights Reduced exercise price Gross proceeds from issuance of warrants Proceeds from raised stock amount Underwriting discounts and commissions Legal fees Stock issued during period shares new issues Proceeds from issuance of private placement Cash fee Stock Issued During Period, Value, Restricted Stock Award, Gross Selling general and administrative expenses Monthly fee Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Number of Shares, Outstanding Weighted Average Grant Date Value per Share, Outstanding Number of Shares, Granted Weighted Average Grant Date Value per Share, Granted Number of Shares, Vested Weighted Average Grant Date Value per Share, Vested Number of Shares, Forfeited Weighted Average Grant Date Value per Share, Forfeited Number of Shares, Outstanding Weighted Average Grant Date Value per Share, Outstanding Vesting restricted stock awards shares Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures Share-Based Compensation Arrangement by Share-Based Payment Award, Terms of Award Recognized share based compensation Unrecognized share-based compensation expenses related to unvested awards Weighted-average period Product Liability Contingency [Table] Product Liability Contingency [Line Items] Lease expiration date Company recognized right of use asset Operating lease liability Lease modification Payment for milestone Commitment payable Net Operating Loss - U.S. Net Operating Loss - Foreign Operating lease liabilities Employee benefits Foreign exchange Total deferred tax assets Less: valuation allowance Deferred tax assets after valuation allowance Operating leases, Right-of-use assets Total deferred tax liabilities Net deferred tax assets U.S. federal statutory rate applies to pretax income (loss) Tax Jurisdiction of Domicile [Extensible Enumeration] U.S. federal statutory rate applies to pretax income (loss), Percentage Different tax rate of subsidiary Different tax rate of subsidiary, percentage Permanent differences Permanent differences. permanent differences Cumulative adjustment to deferred taxes Cumulative adjustment to deferred taxes, percentage Return to provision Return to provision, percentage Change in state tax rates and other Change in state tax rates and other, percentage Change in valuation allowance Change in valuation allowance, percentage Total income tax provision (benefit) and effective income tax rate Total income tax provision (benefit) and effective income tax rate, percentage Effective Income Tax Rate Reconciliation [Table] Effective Income Tax Rate Reconciliation [Line Items] Operating loss carryforwards Net loss attributable to Intelligent Bio Solutions Inc. Basic net loss per share attributed to common shareholders Diluted net loss per share attributed to common shareholders Weighted-average number of shares outstanding, basic Weighted-average number of shares outstanding, diluted Antidilutive Security, Excluded EPS Calculation [Table] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Anti-dilutive Subsequent Event [Table] Subsequent Event [Line Items] Issuance of common stock Research and development tax incentive receivable current. Employee related liabilities noncurrent. Development and regulatory approval expenses. Issuance of common stock, net of issuance costs, values Issuance of common stock, net of issuance costs, shares Stock issued during period value exercise of warrants net issuance costs. Stock issued during period shares exercise of warrants net issuance costs. Noncash refund of research and development rd expenditure claims. Noncash other operating activities. Grant receivable/deferred grant income. Increase decrease in research and development tax incentive receivable. Proceeds from issuance of common stock and warrants. Proceeds from issuance of common stock for warrants exercised, net of issuance costs. Equity issuance costs in accounts payable and accrued expenses. Issuance of common stock upon cashless exercise of Series F warrants. Working capital deficit. 2019 Long Term Equity Incentive Plan [Member] One Customer [Member] Major Suppliers [Member] Equity Offering Costs [Policy Text Block] Other Equipment [Member] Production Equipment [Member] Research and developement tax refund. Government support income Tax credit of refund description. Research and development tax refund. Warrants [Policy Text Block] Employee Benefits [Policy Text Block] Long lived assets. Long lived assets and inventory. Other Country [Member] Acquired finite lived intangible assets useful life. Acquired finite lived intangible assets remaining weighted average useful life. Effect of foreign currency on intangible assets. Accrued compensation and related payables Preferred stock shares designated. Series C Convertible Preferred [Member] Series E Convertible Preferred [Member] ATM Agreement [Member] 2025 March ATM Supplement [Member] Ladenburg Thalmann & Co. Inc [Member] At The Market Offering [Member] Inducement Agreement [Member] Reverse Stock Split [Member] Series G And Series H1 Warrants [Member] Reduced exercise price. Series H-1 Warrants [Member] Series J Warrants [Member] Series H2 Warrants [Member] Underwriting discount and commissions net. Series H2 Preferred Stock [Member] December 2025 Securities Purchase Agreement [Member] Series L Pre-Funded Warrants [Member] Series K-1 Warrants [Member] Series K-2 Warrants [Member] Series K Pre-Funded Warrants [Member] Advisory Agreement [Member] Post-December 2025 Reverse Stock Split [Member] Clear Think Agreement [Member] Monthly fee. 12-month Anniversary [Member] 48-month Anniversary [Member] Performance Based Restricted Stock Awards [Member] Employees [Member] Cambridge England [Member] Lease right of use asset modification. Payments for milestone. CenExel HRI [Member] Cen Exel Clinical Research Inc [Member] Schedule of deferred tax asset and liabilitie [TableTextBlock] Deferred tax assets operating lease liability. Deferred tax liabilities right of use assets. Permanent differences. Cumulative sdjustment to deferred taxes. Return to provision. Effective income tax reconciliation other expiration of net operating loss. Income tax reconciliation income tax expense benefit at different tax rate of subsidiary. Income tax reconciliation permanent differences. Income tax reconciliation cumulative adjustment to deferred taxes. Income tax reconciliation return to provision. Sales of Goods - Cartidges [Member] Sales of Goods - Readers [Member] Other sales - accessories [Member] Software [Member] Warrants [Member] Customer Relationships One [Member] Seriesj Preferred Stock [Member] Series K-1 and Series K-2 Warrants [Member] Government grant refund payable. Accrual other expenses. Accrual research and development expenses. Useful Life, Lease Term [Member] Assets, Current Assets Liabilities, Current Liabilities Treasury Stock, Value Equity, Attributable to Parent Liabilities and Equity Cost of Revenue Gross Profit DevelopmentAndRegulatoryApprovalExpenses Operating Expenses Operating Income (Loss) Interest Expense, Nonoperating Nonoperating Income (Expense) Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest Comprehensive Income (Loss), Net of Tax, Attributable to Parent Shares, Outstanding NoncashRefundOfResearchAndDevelopmentRdExpenditureClaims NoncashOtherOperatingActivities Increase (Decrease) in Accounts Receivable Increase (Decrease) in Inventories IncreaseDecreaseInGrantReceivableAndDeferredGrantIncome IncreaseDecreaseInResearchAndDevelopmentTaxIncentiveReceivable Increase (Decrease) in Other Current Assets Increase (Decrease) in Other Accounts Payable and Accrued Liabilities Cash Provided by (Used in) Operating Activity, Including Discontinued Operation Payments to Acquire Property, Plant, and Equipment Cash Provided by (Used in) Investing Activity, Including Discontinued Operation Cash Provided by (Used in) Financing Activity, Including Discontinued Operation Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Including Discontinued Operation Forgone Recovery, Individual Name Outstanding Recovery, Individual Name Awards Close in Time to MNPI Disclosures, Individual Name Trading Arrangement, Individual Name Cash and Cash Equivalents, Policy [Policy Text Block] Inventory, Policy [Policy Text Block] Lessee, Leases [Policy Text Block] Long-Lived Asset, Excluding Intangible Asset and Goodwill, Impairment and Disposal [Policy Text Block] Government Assistance [Policy Text Block] Concentration Risk, Percentage General and Administrative Expense Accounts Receivable, Allowance for Credit Loss Other Assets, Current Property, Plant, and Equipment, Accumulated Depreciation, Depletion, and Amortization AcquiredFiniteLivedIntangibleAssetsUsefulLife Intangible Asset, Finite-Lived, after Accumulated Amortization Operating Lease, Cost Lessee, Operating Lease, Liability, to be Paid, Year One Lessee, Operating Lease, Liability, to be Paid, Year Two Lessee, Operating Lease, Liability, to be Paid, Year Three Lessee, Operating Lease, Liability, to be Paid, Year Four Lessee, Operating Lease, Liability, to be Paid Lessee, Operating Lease, Liability, Undiscounted Excess Amount Sale of Stock, Consideration Received on Transaction Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Number of Shares Share-Based Compensation Arrangement by Share-Based Payment Award, Option, Nonvested, Weighted Average Exercise Price DeferredTaxAssetsOperatingLeaseLiability Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Benefits Deferred Tax Assets, Valuation Allowance Deferred Tax Liabilities, Net Effective Income Tax Rate Reconciliation, Percent